134 results
Page 3 of 7
8-K
EX-10.3
mhv iz7ls
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-10.1
1gvnhcehd 7f36mid
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-99.1
yfoa7 sdq9gfp5b5q
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
8-K
EX-1.1
5zt06mx
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
424B5
foe37kx22qsruxwu704
29 Sep 22
Prospectus supplement for primary offering
4:08pm
424B5
v0f9ox q5hvvdv
27 Sep 22
Prospectus supplement for primary offering
5:01pm
8-K
EX-10.1
0vvu cfo3vsncj4nqmyj
19 Sep 22
Departure of Directors or Certain Officers
7:06am
8-K
EX-99.1
ul1 kp0yi8v8skqgeu6
19 Sep 22
Departure of Directors or Certain Officers
7:06am
8-K
EX-99.1
e03cb4
15 Aug 22
Gamida Cell Reports Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
z73 rf3mfj
1 Aug 22
Gamida Cell Announces FDA Acceptance of
7:30am
DEF 14A
q5svwc4j0xl1249
22 Jun 22
Definitive proxy
4:22pm
424B7
nxfdzaxdy j2y05d25
14 Jun 22
Prospectus with selling stockholder info
4:26pm
PRE 14A
le9qw
10 Jun 22
Preliminary proxy
4:25pm
8-K
EX-99.1
k3y4rmirj oow
2 Jun 22
Gamida Cell Completes
7:31am
POS AM
mip3to7qdfuz0dv
1 Jun 22
Prospectus update (post-effective amendment)
4:56pm
10-Q
6yk6yj6qi2 3wk6v
12 May 22
Quarterly report
7:42am
8-K
EX-99.1
iuki9zbc
10 May 22
Gamida Cell Reports First Quarter 2022 Financial Results
7:30am
POS AM
88j4r
25 Mar 22
Prospectus update (post-effective amendment)
4:31pm